Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Niger J Clin Pract ; 25(4): 483-489, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35439908

ABSTRACT

Background: Peripartum hysterectomy (PPH), which means surgical removal of the uterus during pregnancy or postpartum period, is a life-saving procedure performed as a last resort to stop obstetric serious bleeding. Aim: Evaluation of the prevalence, risk factors, indications, associated complications, and neonatal outcomes of PPH performed in our clinic. Patients and Methods: A total of 35 patients who underwent PPH in our clinic between 2013 and 2020 were analyzed retrospectively. Clinical and demographic characteristics of patients, age, gestational week, delivery type, type of hysterectomy performed, length of hospital stay, PPH indications, additional procedures and complications during PPH, maternal and fetal mortality, neonatal characteristics, intensive care unit (ICU) need after PPH, and blood transfusion amount and time were recorded. Patients with PPH were subdivided and studied in subgroups: Emergency - elective surgery, total - subtotal hysterectomy. Results: PPH was performed in 35 (3.2/1000) patients who gave birth during the study period. The most common indication for hysterectomy was placental invasion anomaly (57.1%, n = 20), and the most performed operation was total hysterectomy (68.6%, n = 24). Bilateral hypogastric artery ligation (14.3%, n = 5) was the most common alternative procedure performed before hysterectomy, and the most common complication was bladder injury (22.9%, n = 8). Blood transfusion was performed in 94.3% (n = 33) of the patients due to acute blood loss. The mean newborn weight was 2788.79 ± 913.37 g, and the 1st and 5th-minute APGAR scores were 6.71 ± 2.25 and 7.56 ± 2.35, respectively. Conclusion: Before PPH, uterine integrity should be preserved using medical and surgical methods, but if success is not achieved, hysterectomy is the last life-saving step. It should be kept in mind that in patients with anemia and increased gravidity, the risk of bleeding may be high in the first 24 h after birth and therefore PPH may be required. It would be more appropriate for patients with placentation anomalies to be operated in experienced centers due to possible complications, increased blood transfusion, and intensive care requirement.


Subject(s)
Peripartum Period , Postpartum Hemorrhage , Delivery of Health Care , Female , Humans , Hysterectomy/adverse effects , Hysterectomy/methods , Infant, Newborn , Placenta , Postpartum Hemorrhage/epidemiology , Postpartum Hemorrhage/surgery , Pregnancy , Retrospective Studies
2.
J Mol Model ; 27(6): 174, 2021 May 21.
Article in English | MEDLINE | ID: mdl-34021419

ABSTRACT

In this paper, three organic semiconductors such as 9-[(5-nitropyridin-2-aminoethyl)iminiomethyl]-anthracene (a), N'-((pyren-4-yl)methylene)isonicotinohydrazide (b), and novel organic semiconductor N-(2-((pyren-4-yl)methyleneamino)ethyl)-5-nitropyridin-2-amine (c) were prepared. Their structures were assessed using NMR and elemental analysis techniques. While compound (a) and compound (c) have the same wing unit ([(5-nitropyridin-2-aminoethyl) iminiomethyl]), compounds (b) and (c) have the same core unit (5-nitropyridin-2-amine). Based on TD-DFT and Marcus theories, we have explored the effects of molecular structure on the opto-electronic properties for OLED applications. Our results show that wing units of molecules impact more on the opto-electronics properties than on core units. The compounds (a) and (c) with the same wing unit have exhibited quite similar behaviors in terms of both structural and opto-electronic parameters. However, a similar situation has not been observed for compounds (b) and (c) with the same core unit. In conclusion, our results indicate that compounds (a) and (c) exhibit obvious advantages for OLEDs in terms of calculated opto-electronic and charge transport properties such as better absorption and emission parameters, lower energy gaps and reorganisation energies and higher charge mobility.

3.
Cardiovasc J Afr ; 21(3): 137-41, 2010.
Article in English | MEDLINE | ID: mdl-20532451

ABSTRACT

INTRODUCTION: The aim of the study was to assess the midterm results of left atrial bipolar radiofrequency ablation combined with a mitral valve procedure in patients with mitral valve disease and persistent atrial fibrillation. METHODS: Between October 2006 and July 2009, 95 patients with mitral valve disease and persistent atrial fibrillation underwent a mitral valve procedure and left atrial bipolar radiofrequency ablation. The postoperative data of the combined procedure were collected at the time of discharge and at one, three, six and 12 months after the operation. RESULTS: Hospital mortality rate was 6.3% (six patients). Normal sinus rhythm was achieved in 77.2% of patients during the early postoperative period in hospital, and in 73.3, 72.0 and 75% of patients at three, six and 12 months postoperatively, respectively. Patients were followed up for a mean duration of 14.02 + or - 5.71 months (range: 6-19 months). During this midterm follow-up period, nine patients had late recurrence of atrial fibrillation. No risk factor was identified for late recurrence of atrial fibrillation. CONCLUSION: Our midterm follow-up results suggest that the addition of left atrial bipolar radiofrequency ablation to mitral valve surgery is an effective and safe procedure to restore sinus rhythm in patients with chronic atrial fibrillation.


Subject(s)
Atrial Fibrillation/surgery , Cardiac Surgical Procedures , Catheter Ablation , Heart Valve Diseases/surgery , Mitral Valve/surgery , Adult , Aged , Atrial Fibrillation/complications , Atrial Fibrillation/mortality , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/mortality , Cardiopulmonary Bypass , Catheter Ablation/adverse effects , Catheter Ablation/mortality , Chi-Square Distribution , Chronic Disease , Female , Heart Valve Diseases/complications , Heart Valve Diseases/mortality , Heart Valve Prosthesis Implantation , Hospital Mortality , Humans , Male , Middle Aged , Recurrence , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome , Turkey , Young Adult
4.
Clin Lab Haematol ; 28(3): 170-6, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16706933

ABSTRACT

The incidence of hematological malignancies during pregnancy is low, and treatment in this setting is problematic. This study observed 21 pregnancies in 18 patients with hematological malignancies. Patients' ages were between 19 and 43 (median 25) years. Two pregnancies ended with spontaneous abortion, one pregnancy ended with in utero death, three therapeutic abortions were carried out, and 15 infants were born alive but three of them died later. The median birth weight was 2.47 kg. Twelve babies survived to a median age of 36 (range 4-117) months. Eight babies were exposed to chemotherapy during the in utero period. One baby was exposed to chemotherapy during all the trimesters and was born prematurely and later died because of intracranial bleeding. Four babies were exposed to chemotherapy during the first trimester, one of them had low birth weight and floating thumb malformation, two of them had only low birth weight, and one was born healthy, but died at 3 months of age as a result of severe gastroenteritis. Two babies were exposed to chemotherapy during the second and third trimesters; one of them had low birth weight, and the other pregnancy ended in in utero death. One infant was exposed to chemotherapy during the third trimester and was born at term, but died because of pulmonary hemorrhage. We concluded that chemotherapy during all trimesters of pregnancy carries a significant risk for an unfavorable outcome.


Subject(s)
Fetus/drug effects , Pregnancy Complications, Hematologic/drug therapy , Pregnancy Complications, Neoplastic/drug therapy , Abortion, Spontaneous/chemically induced , Abortion, Therapeutic , Adult , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Fatal Outcome , Female , Fetus/abnormalities , Hodgkin Disease/drug therapy , Humans , Infant, Newborn , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myeloid, Acute/drug therapy , Lymphoma, Non-Hodgkin/drug therapy , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Pregnancy
5.
Int J Clin Pract ; 58(12): 1115-7, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15646407

ABSTRACT

Because of immunity defect, patients with end-stage renal disease are at increased risk of developing infections, tuberculosis (TB) in particular. The incidence of TB is higher in dialysis patients than in general population. We retrospectively reviewed the charts of dialysis patients with TB in our facility. A total of 287 dialysis patients (153 male, 134 female, 223 haemodialysis (HD), 64 continuous ambulatory peritoneal dialysis (CAPD) patients, mean age 46 +/- 15) were reviewed from October 1997 to January 2002. TB developed in 30 patients (17 male, 13 female, 24 HD and six CAPD). Thirteen patients with TB presented with fever of unknown origin (FUO) and four of them subsequently developed military lesions on chest X-ray. Nine patients had pulmonary TB (four with pleural effusions), five patients had TB lymphadenits, two patients had TB peritonitis and one patient had vertebral TB. TB was presented mostly as FUO among dialysis patients in a region under poor socio-economic conditions. In such areas with endemic TB, dialysis patients who present with FUO should be carefully evaluated for the presence of TB, and test therapy for TB should be performed in otherwise unexplained FUO.


Subject(s)
Kidney Failure, Chronic/complications , Opportunistic Infections/etiology , Renal Dialysis , Tuberculosis/etiology , Adult , Antitubercular Agents/therapeutic use , Endemic Diseases , Female , Humans , Kidney Failure, Chronic/epidemiology , Kidney Failure, Chronic/therapy , Male , Middle Aged , Opportunistic Infections/epidemiology , Prevalence , Retrospective Studies , Risk Factors , Tuberculosis/drug therapy , Tuberculosis/epidemiology , Turkey/epidemiology
6.
Acta Chir Belg ; 102(3): 207-9, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12136544

ABSTRACT

As a complication of hydatid cyst disease of the liver, bronchobiliary fistula is a rare condition and manifests as bilioptysis. We report the case of a 34 year-old man with echinococcosis of the liver who developed a bronchobiliary fistula which manifested as chronic cough and bile stained sputum. A chest X-ray showed an unilateral infiltrate in the costodiaphragmatic angle. Bronchoscopy revealed bile filling the right basal bronchi. Magnetic resonance cystography revealed that the hepatic bile ducts communicated with the right basal pleural space. Percutaneous transhepatic drainage was applied. When the patient was reevaluated, the hydatid cyst had eroded into the pleural space, and a pleural effusion had developed. The condition of the patient deteriorated. Hence, surgical therapy was performed. After surgery, the condition of the patient improved. He was discharged from the hospital in good condition.


Subject(s)
Biliary Fistula/etiology , Bronchial Fistula/etiology , Echinococcosis, Hepatic/complications , Adult , Bronchial Fistula/diagnostic imaging , Bronchial Fistula/parasitology , Echinococcosis, Hepatic/diagnosis , Echinococcosis, Hepatic/parasitology , Humans , Magnetic Resonance Imaging , Male , Radiography
8.
Acta Chir Belg ; 101(4): 190-2, 2001.
Article in English | MEDLINE | ID: mdl-11680063

ABSTRACT

The pancreas is a rare site of metastasis from small-cell lung cancer (SCLC). We present the case of a pancreatic metastasis of small-cell lung cancer associated with jaundice, in which, initially, the case was evaluated as a primary pancreatic carcinoma and pancreaticoduodenectomy was performed. We also review the reported cases of pancreatic metastases from SCLC.


Subject(s)
Carcinoma, Small Cell/secondary , Cholestasis, Extrahepatic/etiology , Lung Neoplasms/pathology , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/secondary , Bile Ducts, Intrahepatic/pathology , Carcinoma, Small Cell/complications , Common Bile Duct/pathology , Dilatation, Pathologic , Humans , Lung Neoplasms/complications , Male , Middle Aged , Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy
9.
Respirology ; 6(3): 255-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11555385

ABSTRACT

OBJECTIVE: The aim of this study was to describe the lung function and the computed tomographic features in a selected group of non-smoking women with chronic obstructive pulmonary disease and biomass fuel exposure. METHODOLOGY: Thirty female patients currently exposed to biomass smoke were prospectively investigated for further evaluation using high resolution computed tomography (HRCT), pulmonary function tests and blood gas analysis. RESULTS: The mean age was 59 +/- 11 years. The patients were exposed to biomass smoke for 37.4 +/- 10 years. Pulmonary function tests revealed severe obstruction. The most common HRCT findings were increased lung volume or diffuse emphysema, thickening of interlobular septae, focal emphysematous areas, increased cardiothoracic ratio, and increased bronchovascular arborization. CONCLUSION: Biomass fuel has deleterious effects on pulmonary function and structure leading to obstructive and restrictive pathologies.


Subject(s)
Air Pollution, Indoor , Environmental Exposure , Pulmonary Disease, Chronic Obstructive/physiopathology , Aged , Female , Humans , Middle Aged , Prospective Studies , Pulmonary Disease, Chronic Obstructive/diagnostic imaging , Spirometry , Tomography, X-Ray Computed
10.
Eur Respir J ; 17(5): 863-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11488317

ABSTRACT

This study investigated the effects of beta2-adrenergic agonist therapy on heart rate variability (HRV) in adult asthmatic patients by using frequency domain measures of HRV. A randomized crossover design was used. Twenty adult patients with asthma were studied. All patients showed a mild-to-moderate decrease in baseline forced expiratory volume in one second. Any diseases that might have influenced the autonomic function were excluded. All patients had a complete physical examination and medical history that revealed no cardiovascular disease or medication. The study used 200 microg inhaled salbutamol and 500 microg inhaled terbutaline. HRV analysis was performed for each 5-min segment, 5 min before inhalation of the study drug and 5, 10, 15, 20, 25 and 30 min after inhalation. Total power (TP: <0.40 Hz), high-frequency power (HF: 0.15-0.40 Hz), low-frequency power (LF: 0.04-0.15 Hz) and LF/HF ratio were calculated. The LF and LF/HF ratio increased and TP decreased at 5, 10, 15 and 20 min after the salbutamol and the terbutaline inhalation, HF did not change significantly after the salbutamol and terbutaline inhalation. Acute salbutamol and terbutaline inhalation produce similar effects on heart rate variability and increase sympathetic modulation in the cardiac autonomic activity.


Subject(s)
Albuterol/adverse effects , Asthma/drug therapy , Heart Rate/drug effects , Terbutaline/adverse effects , Administration, Inhalation , Adult , Albuterol/administration & dosage , Autonomic Nervous System/drug effects , Cross-Over Studies , Electrocardiography, Ambulatory/drug effects , Female , Humans , Male , Middle Aged , Terbutaline/administration & dosage
11.
Angiology ; 52(5): 317-22, 2001 May.
Article in English | MEDLINE | ID: mdl-11386382

ABSTRACT

Cardiac troponin levels are regarded as the most specific of currently available biochemical markers of myocardial damage. Elevated levels of troponin have been previously reported in patients with left heart failure, reflecting small areas of undetected myocardial cell death. The aim of this study was to compare the levels of the cardiac troponin I (cTnI) in patients with left- and right-sided heart failure. Cardiac troponin I levels were studied with immunochemical methods in patients with right heart failure (n = 17) resulting from chronic obstructive pulmonary disease, ischemic left heart failure (n = 23), and nonischemic left heart failure (n = 18) who were admitted to departments of cardiology and chest diseases. Also, cTnI levels were measured in 32 healthy subjects as control group. Protein markers of myocardial injury (cTnI and myoglobin) in patients with left and right heart failure were collected approximately 12 to 36 hours after onset of obvious symptoms. Serum creatine kinase MB band was determined on admission and thereafter twice a day during the first 3 days. Elevated levels of serum cTnI were found in patients with nonischemic (0.83 +/- 0.6 ng/mL, p<0.01) and ischemic left heart failure (0.9 +/- 0.5 ng/mL, p<0.01) when compared to healthy subjects, whereas serum cTnI levels in patients with right heart failure due to chronic obstructive pulmonary disease were not significantly different from those of control subjects (0.22 +/- 0.1 vs 0.16 +/- 0.1 ng/mL, p>0.05). In addition, creatine kinase MB band and myoglobin levels were not significantly different between patient and healthy groups. The mean of cTnI levels in ischemic and even nonischemic left heart failure were increased compared to the mean of values in healthy individuals but without significant creatine kinase MB band and myoglobin elevations. But cTnI levels were not increased in patients with right heart failure due to chronic obstructive pulmonary disease. These data indicate that the cTnI levels are abnormal in left heart failure but not in cor pulmonale.


Subject(s)
Pulmonary Heart Disease/blood , Troponin I/blood , Ventricular Dysfunction, Left/blood , Ventricular Dysfunction, Right/blood , Adult , Aged , Biomarkers/blood , Female , Humans , Immunohistochemistry , Lung Diseases, Obstructive/blood , Male , Middle Aged
12.
Can Respir J ; 7(6): 476-80, 2000.
Article in English | MEDLINE | ID: mdl-11121092

ABSTRACT

Levels of vitamin C, ceruloplasmin, transferrin and albumin in serum, and glutathione in red blood cells were investigated in 40 patients with asthma to determine whether their antioxidant status was different from healthy subjects. Serum vitamin C and albumin levels were lower in the patient group (36.91+/-12.50 microM and 46.2+/-3.0 g/L, respectively) than in 43 healthy volunteers (53.38+/-13.06 microM and 48.8+/-2.1 g/L, P<0.001 and P<0.05, respectively). However, erythrocyte glutathione and serum ceruloplasmin levels were higher in the patient group (0.59+/-0.11 mol/mol hemoglobin and 442+/-73 micromol/L, respectively) than in controls (0.49+/-0.09 mol/mol hemoglobin and 308+/-47 micromol/L, P<0.001 and P<0.001, respectively). No difference was observed in transferrin levels between the groups. The results suggest that reactive oxygen species may be a contributing factor in patients with asthma, causing changes in serum vitamin C, ceruloplasmin and erythrocyte glutathione levels.


Subject(s)
Antioxidants/analysis , Asthma/blood , Erythrocytes/chemistry , Adolescent , Adult , Aged , Ascorbic Acid/blood , Asthma/physiopathology , Ceruloplasmin/analysis , Female , Glutathione/analysis , Humans , Lipid Peroxidation , Male , Middle Aged , Serum Albumin/analysis , Transferrin/analysis
13.
Acta Cardiol ; 55(5): 301-5, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11103830

ABSTRACT

BACKGROUND: The effects of cigarette smoking on the circadian rhythm of heart rate variability (HRV) are not known. METHODS: We studied the effects of cigarette smoking on the circadian rhythm of HRV in 24 smoking and 21 non-smoking healthy subjects. Twenty-four hour ambulatory electrocardiograms were recorded and time domain parameters of HRV (SDNN [standard deviation of all R-R intervals], SDANN [standard deviation of the averages of R-R intervals in all 5-minute segments of the entire recording], RMSSD [the square root of the mean of the sum of the squares of differences between adjacent R-R intervals]) were determined for the entire 24-hour period and for each 3-hour period. RESULTS: In total, SDNN and SDANN were significantly lower in smokers than non-smokers (116 +/- 26 vs 136 +/- 27, p < 0.05 for SDNN, 109 +/- 25 vs 121 +/- 24, p < 0.05 for SDANN). However, there were no statistical differences between smokers and non-smokers in heart rate (81 +/- 9 vs 76 +/- 10, p > 0.05) and RMSSD (32 +/- 12 vs 37 +/- 18, p > 0.05). These HRV parameters showed a circadian variation: they increased at night and decreased during the day in both groups. The parameters were lower in smokers than non-smokers during daytime (especially, between 8-14 hours). However, no differences were detected during night-time. CONCLUSIONS: Time domain parameters of HRV (SDNN, SDANN and RMSSD) in both smoking and non-smoking healthy subjects have a circadian rhythm. SDNN and SDANN were lower in smokers than non-smokers during daytime.


Subject(s)
Circadian Rhythm , Heart Rate/physiology , Smoking/physiopathology , Adult , Electrocardiography, Ambulatory , Female , Humans , Male
14.
Clin Chem Lab Med ; 38(7): 661-5, 2000 Jul.
Article in English | MEDLINE | ID: mdl-11028772

ABSTRACT

Uric acid is known to be an end product of purine metabolism. Increases in uric acid may be found in clinical conditions associated with tissue hypoxia. We have investigated the value of uric acid to differentiate between a transudate and exudate. In this study, we measured uric acid in the pleural fluid and the serum of 110 patients, 30 women and 80 men with a mean age of 49.5+/-19 years. Light's criteria were used to differentiate between a transudate and exudate. Mean serum uric acid was 496.7+/-153.4 micromol/l in patients with transudates and 291.3+/-143.1 micromol/l in patients with exudates. Mean pleural fluid uric acid was 487.7+/-165 micromol/l in patients with transudates and 279.9+/-142.1 micromol/l in patients with exudates. These data showed that the levels of serum and pleural uric acid were higher in transudates than exudates (p<0.01). However, there was no significant difference between pleural fluid/serum uric acid ratio of the two patient groups (p>0.05). The specificity and sensitivity of pleural uric acid for diagnosis of transudate effusions were 73% and 80.6%, respectively. The specificity and sensitivity of pleural uric acid for diagnosis of transudate effusions from exudates without malignancy were 71.8% and 91.7%, respectively. The sensitivity and specificity of pleural lactate dehydrogenase for diagnosis of exudates were 82% and 89%; the sensitivity and specificity of pleural fluid/serum lactate dehydrogenase were 85% and 89%; the sensitivity and specificity of pleural fluid/serum protein were 91% and 89%, respectively. Using all three of Light's criteria together, the sensitivity was 91% and its specificity was 94%. Our findings indicate that determination of uric acid in pleural fluid may be of diagnostic value in differential diagnosis of transudates and exudates. The sensitivity of pleural uric acid measurement was higher for exudates without malignancy. However, Light's criteria remain the best means of separating transudates from exudates.


Subject(s)
Exudates and Transudates/chemistry , Pleural Effusion/chemistry , Uric Acid/blood , Adult , Aged , Exudates and Transudates/metabolism , Female , Humans , Male , Middle Aged , Predictive Value of Tests , ROC Curve , Sensitivity and Specificity
15.
J Trace Elem Med Biol ; 14(2): 88-91, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10941719

ABSTRACT

In this study, serum copper, zinc, magnesium, iron and calcium concentrations were investigated in 40 patients with bronchial asthma (BA) and in 43 healthy subjects. Copper and calcium levels were found to be increased in patients with BA compared to the control group (p < 0.001 and p < 0.001 respectively). On the other hand, the serum zinc level was significantly lower in healthy subjects (p < 0.01). No changes were found in serum magnesium and iron levels in patients with BA compared to controls. In addition to various elements, certain serum proteins such as albumin, transferrin and ferritin were also assessed to determine whether there was a relationship between the elements and proteins in patients with BA. There was only a significant decrease in albumin concentration in patients with BA (p < 0.05).


Subject(s)
Asthma/blood , Copper/blood , Zinc/blood , Adolescent , Adult , Aged , Albumins/metabolism , Calcium/blood , Case-Control Studies , Female , Ferritins/blood , Humans , Iron/blood , Magnesium/blood , Male , Middle Aged , Oxidative Stress , Transferrin/metabolism
16.
Clin Imaging ; 24(6): 347-50, 2000.
Article in English | MEDLINE | ID: mdl-11368935

ABSTRACT

The aim of this study was to show reduction of the diaphragmatic excursion with MR fluoroscopy in patients with chronic obstructive pulmonary disease (COPD) and to compare the results with pulmonary function test (PFT). The study included 13 men and 10 women (average age 56.2) with COPD, and 9 men and 6 women (average age 55.8) as a control group. MR fluoroscopy images with Spoiled Gradient-echo pulse sequence was obtained during deep inspiration and expiration. After examination, over cine-loop display, the highest and lowest positions of the diaphragm were identified and the distance of excursion was measured. Differences in the diaphragmatic excursion between patient and healthy subjects were compared. We have also compared MR fluoroscopy results with PFT. In each person of both groups, excursion of the diaphragm was demonstrated clearly in cine-loop display. Differences of excursion between deepest and highest point of diaphragm were on average 26 and 20 mm, respectively, in the right and left side in patients and 69 and 56 mm in healthy group. Significant correlation was found between expiratory volume in 1 s and MR fluoroscopy results. MR fluoroscopy study showed that there were significant statistical differences in diaphragmatic excursion between patients with COPD and healthy subjects. Expiratory volume in 1 s is closely associated with the diaphragmatic excursion. MR fluoroscopy would seem to be a useful method for showing diaphragmatic excursion.


Subject(s)
Diaphragm/pathology , Lung Diseases, Obstructive/diagnosis , Magnetic Resonance Imaging/methods , Adult , Aged , Diaphragm/physiopathology , Female , Fluoroscopy , Forced Expiratory Volume , Humans , Lung Diseases, Obstructive/physiopathology , Male , Middle Aged , Respiratory Function Tests
SELECTION OF CITATIONS
SEARCH DETAIL